Tumoral LINE-1 hypomethylation is associated with poor survival of patients with intrahepatic cholangiocarcinoma

被引:0
作者
Seorin Jeong
Kyoungbun Lee
Xianyu Wen
Younghoon Kim
Nam-Yun Cho
Ja-June Jang
Gyeong Hoon Kang
机构
[1] Seoul National University College of Medicine,Laboratory of Epigenetics, Cancer Research Institute
[2] Seoul National University College of Medicine,Department of Pathology
[3] Seoul National University College of Medicine,Laboratory of Epigenetics, Cancer Research Institute, Department of Pathology
来源
BMC Cancer | / 17卷
关键词
Cholangiocarcinoma; Line-1; Methylation; Prognosis; Pyrosequencing;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 129 条
[1]  
Karpf AR(2005)Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells Cancer Res 65 8635-8639
[2]  
Matsui S(2013)Long interspersed element-1 (LINE-1): passenger or driver in human neoplasms? PLoS Genet 9 e1003402-8846
[3]  
Rodic N(2004)Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis Oncogene 23 8841-5037
[4]  
Burns KH(2012)DNA demethylation in normal colon tissue predicts predisposition to multiple cancers Oncogene 31 5029-6836
[5]  
Chalitchagorn K(2005)Analysis of repetitive element DNA methylation by MethyLight Nucleic Acids Res 33 6823-1281
[6]  
Shuangshoti S(2010)Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer N Engl J Med 362 1273-1229
[7]  
Hourpai N(2013)Pathogenesis, diagnosis, and management of cholangiocarcinoma Gastroenterology 145 1215-522
[8]  
Kongruttanachok N(2011)Clinical diagnosis and staging of cholangiocarcinoma Nat Rev Gastroenterol Hepatol 8 512-2177
[9]  
Tangkijvanich P(2011)AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: by the AFC-IHCC-2009 study group Cancer 117 2170-70
[10]  
Thong-ngam D(2016)Proposal of a new staging system for intrahepatic cholangiocarcinoma: analysis of surgical patients from a nationwide survey of the liver cancer study Group of Japan Cancer 122 61-487